Jove
Visualize
联系我们
JoVE
x logofacebook logolinkedin logoyoutube logo
关于 JoVE
概览领导团队博客JoVE 帮助中心
作者
出版流程编辑委员会范围与政策同行评审常见问题投稿
图书馆员
用户评价订阅访问资源图书馆顾问委员会常见问题
研究
JoVE JournalMethods CollectionsJoVE Encyclopedia of Experiments存档
教育
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab Manual教师资源中心教师网站
使用条款与条件
隐私政策
政策

相关概念视频

您也可能阅读

相关文章

通过共同作者、期刊和引用图与本文相关的文章。

排序
Same author

Concurrent administration of BCMA and GPRC5D chimeric antigen receptor (CAR) T cells in advanced multiple myeloma.

Blood·2026
Same author

ATG Exposure in T Replete Transplant for Hematological Malignancies: Real World Analysis from BMT CTN 1202.

Research square·2026
Same author

Intravesical mesothelin-based CAR T cells targeting MUC16 effectively control bladder cancer in preclinical models.

The Journal of experimental medicine·2026
Same author

Association Between Amyloid Deposition and Collagen-to-Elastin Ratio in the Ligamentum Flavum: A Machine Learning Histologic Study in Matched Groups.

Neurosurgery·2026
Same author

Yes, we can omit TBI for ALL!

Blood advances·2026
Same author

Prognostic impact of ASXL1 mutations in acute myeloid leukemia treated with lower intensity therapy.

Cancer·2026

相关实验视频

Updated: Jun 25, 2025

Manufacturing Chimeric Antigen Receptor CAR T Cells for Adoptive Immunotherapy
06:51

Manufacturing Chimeric Antigen Receptor CAR T Cells for Adoptive Immunotherapy

Published on: December 17, 2019

15.0K

开发一种膜附近的向CD33的CAR T细胞.

Ruby Freeman1, Sanam Shahid1, Abdul G Khan1

  • 1Memorial Sloan Kettering Cancer Center, New York, New York, USA.

Journal for immunotherapy of cancer
|May 21, 2024
PubMed
概括
此摘要是机器生成的。

针对CD33的膜近接域与新型仿真抗原受体 (CAR) T细胞,3P14HLh28Z,在急性髓性白血病 (AML) 模型中表现出优异的疗效,与准远端表观的CAR T细胞相比.

关键词:
收养细胞疗法 - ACT化学抗原受体 - - CAR免疫治疗是一种免疫疗法.在白血病中,白血病.一个T细胞细胞.

更多相关视频

Generation of CAR T Cells for Adoptive Therapy in the Context of Glioblastoma Standard of Care
12:55

Generation of CAR T Cells for Adoptive Therapy in the Context of Glioblastoma Standard of Care

Published on: February 16, 2015

21.4K
Clinical Application of Sleeping Beauty and Artificial Antigen Presenting Cells to Genetically Modify T Cells from Peripheral and Umbilical Cord Blood
09:29

Clinical Application of Sleeping Beauty and Artificial Antigen Presenting Cells to Genetically Modify T Cells from Peripheral and Umbilical Cord Blood

Published on: February 1, 2013

18.4K

相关实验视频

Last Updated: Jun 25, 2025

Manufacturing Chimeric Antigen Receptor CAR T Cells for Adoptive Immunotherapy
06:51

Manufacturing Chimeric Antigen Receptor CAR T Cells for Adoptive Immunotherapy

Published on: December 17, 2019

15.0K
Generation of CAR T Cells for Adoptive Therapy in the Context of Glioblastoma Standard of Care
12:55

Generation of CAR T Cells for Adoptive Therapy in the Context of Glioblastoma Standard of Care

Published on: February 16, 2015

21.4K
Clinical Application of Sleeping Beauty and Artificial Antigen Presenting Cells to Genetically Modify T Cells from Peripheral and Umbilical Cord Blood
09:29

Clinical Application of Sleeping Beauty and Artificial Antigen Presenting Cells to Genetically Modify T Cells from Peripheral and Umbilical Cord Blood

Published on: February 1, 2013

18.4K

科学领域:

  • 免疫学 免疫学 免疫学
  • 在瘤学瘤学.
  • 生物技术是生物技术.

背景情况:

  • 在急性髓性白血病 (AML) 中,CD33 是嵌合式抗原受体 (CAR) T 细胞治疗的标.
  • 目前针对CD33的CAR T细胞疗法尚未取得临床成功.

研究的目的:

  • 开发一种新的CD33导向的CAR T细胞疗法,以提高疗效.
  • 为了研究准膜近接与膜远距离CD33表位的影响.

主要方法:

  • 在人性化小鼠中开发了一种新的CD33导向的CAR T细胞 (3P14HLh28Z),使用来自膜近接片段免疫的高亲和度结合剂.
  • 将3P14HLh28Z与临床验证的向远端CD33表位细胞的CAR T细胞进行了比较,在体外和体内模型中.

主要成果:

  • 用CD33的膜近接域免疫对于识别有效的结合剂至关重要.
  • 在AML模型中,3P14HLh28Z表现出增强的体外功能,优越的瘤控制和增加的整体存活率.
  • 增加T细胞激活和多功能性与增强的抗白血病疗效相关.

结论:

  • 这项研究表明,与向膜近端CD33表位细胞具有高亲和结合剂,与向膜远端表位细胞相比,产生更高的CAR T细胞疗效.
  • 优化CAR T细胞在低抗原密度和患者衍生模型中的功能对于治疗成功至关重要.